In the past three decades since the inception of human organ transplantation,
cytomegalovirus (CMV) has gained increasing clinical import because it is a common …

Infectious diseases after solid organ transplantation (SOT) are a significant cause of
morbidity and reduced allograft and patient survival; however, the influence of infection on …

Impact of early cytomegalovirus infection and disease on long-term recipient and kidney
graft survival. Background The impact of cytomegalovirus (CMV) infection and disease on …

Background. Antiviral prophylaxis has been shown to decrease the incidence of
cytomegalovirus (CMV) disease in organ transplant recipients, but whether CMV disease …

Over the past 30 years, organ transplantation has been transformed from an interesting
experiment in human immunobiology to the most practical means of rehabilitating patients …

Human cytomegalovirus (HCMV) is associated with the acceleration of a number of vascular
diseases such as atherosclerosis, restenosis, and transplant vascular sclerosis (TVS). All of …

Background. The incidence and impact of cytomegalovirus (CMV) disease that occurs
despite CMV prophylaxis among liver transplant recipients have been incompletely defined …

The correlation between the prototype AMPLICOR CMV MONITOR test (Roche Molecular
Systems), a quantitative PCR assay, and the cytomegalovirus (CMV) pp65 antigenemia …

Transplant recipients receiving immunosuppressive therapy are at increased risk of active
cytomegalovirus (CMV) infection and disease. Without appropriate prophylaxis, as many as …

Clinical practice guidelines recommend antiviral prophylaxis to cytomegalovirus (CMV)
donor‐positive/recipient‐negative (D+/R−) liver transplant recipients. We assessed the …